1. Sofosbuvir: a novel treatment option for chronic hepatitis C infection;Bhatia;J. Pharmacol. Pharmacother.,2014
2. Sofosbuvir and velpatasvir for the treatment of hepatitis C virus in patients coinfected with human immunodeficiency virus type 1: an open-label, phase 3 study;Wyles;Clin. Infect. Dis.,2017
3. A stability indicating RP-HPLC method for simultaneous estimation of velpatasvir and sofosbuvir in combined tablet dosage forms;Nalla;World J. Pharm. Pharm. Sci.,2017
4. Stability indicating RP-HPLC method development and validation for simultaneous estimation of sofosbuvir and velpatasvir in tablet;Patel;World J. Pharm. Pharm. Sci.,2018
5. A new RP-HPLC method development and validation for simultaneous estimation of sofosbuvir and velpatasvir in pharmaceutical dosage form;Rani;Int. J. Eng. Technol. Sci. Res.,2017